Mal-(CH2)5-Val-Cit-PAB-Eribulin is an agent-linker conjugate designed for antibody-drug conjugates (ADCs) and demonstrates robust antitumor activity. It incorporates the anti-microtubule agent Eribulin, which is employed in the study of metastatic breast cancer.
Products > ADC Linker, ADC Payload > ADC Payload | Products > ADC Linker, ADC Payload > ADC Payload > Eribulin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.